William Schatz is currently a director for CarVal Investors, responsible for managing investments in North American corporate securities. William has been involved in the distressed credit and restructuring space since 2006, with prior experience at Intermarket Corporation, Jefferies, Fintech Advisory, and UBS. He started his finance career in 2001 as a healthcare banker focused on life science tools, diagnostics, and biotechnology companies. William received his A.B in molecular biology from Princeton University.
There were no results found.